CG Invites Co., Ltd.

Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.

083790 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 강서구 마곡중앙8로 38 마곡동, 강서구
Website:: https://cginvites.com/en
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized precision medicine. Leveraging its core competency in developing novel chemical and biological drugs—such as Acelex (osteoarthritis), Ivaltinostat (pancreatic cancer), and Camrelizumab (immuno-oncology)—the company has expanded its focus to several key areas. These include whole genome sequencing, contributing to large-scale bio-data projects; the development of personalized, mRNA-based cancer vaccines targeting tumor-specific neoantigens; and digital therapeutics (DTx), exemplified by its HealthOnG platform for diabetes management. The company's strategy is to innovate within the digital genome market by integrating its drug development expertise with cutting-edge genomic and digital health technologies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for CG Invites Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-08-14 00:00	Interim Report 반기보고서 (2025.06)	Korean	1.8 MB
2025-08-14 00:00	Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서	Korean	34.7 KB

Automate Your Workflow. Get a real-time feed of all CG Invites Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CG Invites Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Psych Capital Plc A life sciences firm developing psilocybin treatments for anorexia and mental health conditions.	United Kingdom	PSY
Pure Biologics S.A. Develops novel antibody & aptamer drugs for immuno-oncology and autoimmune diseases.	Poland	PUR
Puretech Health PLC A clinical-stage biotherapeutics company developing new medicines for devastating diseases.	United States of America	PRTC
PZ Cormay S.A. Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.	Poland	CRM
Quantum Genomics Biopharma developing cardiovascular treatments, now in judicial liquidation.	France	ALQGC
Quratis Inc. Develops infectious disease vaccines and offers biologics CDMO services for global health.	South Korea	348080
Recordati Industria Chimica e Farmaceutica Global pharma group developing drugs for common/rare diseases & supplying APIs worldwide.	Italy	REC
Rekah Pharmaceutical Prod Ltd. A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.	Israel	REKA
Replek AD Manufactures & distributes generic medicines, supplements, and cosmetic products to over 25 countries.	North Macedonia	REPL
Respiratorius AB Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.	Sweden	RESP